Lalitpur pharma park: U.P. eyes one lakh crore investment, 1.5 lakh jobs

A pharma park spanning over 2,000 acres is to come up in Lalitpur, which will accommodate up to 70 manufacturing units.

The park is expected to attract an investment of Rs 1 lakh crore into the state, a press statement issued by the state government on Monday read.

This development is expected to generate more than 1.5 lakh job opportunities. Supporting industries related to pharma will indirectly create 3 lakh jobs, the release read further.

The state government will provide 94 plots in the park, in which plots will range from five acres to 50 acres. This includes three plots of 50 acres, five of 30 acres, eight of 20 acres, 15 plots of 15 acres, 20 plots of 10 acres, and 43 plots of five acres each. Out of the total area, the government will provide plots for industry set-ups in 53%, while the remaining portion will be allocated for other facilities, the statement read.

The park will also allocate 60 acres for residential (housing group) and 40 acres for commercial activities.

Ensuring smooth power supply and upgrading the airport is also in the plan. Additionally, a check-dam reservoir and a pumping station will be constructed on the Jamni River at an estimated cost of 60 crore.

Along with this, about 12 types of concessions will be given to the industry to set up plants in UP. These include interest subsidy, SGST refund, exemption from stamp duty and registration charges, electric duty exemption, EPF reimbursement, hire subsidy, air cargo handling subsidy, patent registration subsidy, quality certification subsidy, skill development incentive, and others.

Related Posts

  • Pharma
  • July 26, 2024
  • 111 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 105 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD